Clinical Trial Update: Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for nanocrystalline Megestrol Acetate aimed at treating cachexia in patients with stage locally advanced hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia
• Hepatocellular Carcinoma

Drugs mentioned

• Nanocrystalline Megestrol Acetate (megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Cachexia, Hepatocellular Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING